Collections

Business on the Front Lines

News and perspectives from corporations working to directly impact the COVID-19 public health crisis. Content from this collection may include updates from medical supply or pharmaceutical companies, businesses that have pivoted their production to support the medical response to COVID-19 or hospitals that are navigating many secondary impacts of the pandemic (both economic and human).

Moderna, Pfizer Coronavirus Vaccines Begin Final-Stage Testing - WSJ

Moderna, Pfizer Coronavirus Vaccines Begin Final-Stage Testing

By: Peter Loftus and Jared S. Hopkins
Source: The Wall Street Journal
Date of Publication: July 27th, 2020
Drugmakers to enroll 30,000 subjects across U.S., in separate trials to determine whether their vaccines prevent symptomatic Covid-19
Moderna loses challenge to Arbutus patent on vaccine technology

Moderna loses challenge to Arbutus patent on vaccine technology

By: Jan Wolfe
Source: Reuters
Date of Publication: July 23rd, 2020
Shares of Moderna Inc fell nearly 10% after it lost a bid to invalidate a U.S. patent owned by Arbutus Biopharma that poses a potential obstacle to Moderna’s efforts to develop next-generation vaccines, including a coronavirus vaccine.
Oxford University's coronavirus vaccine with AstraZeneca shows positive immune response in early trial

Coronavirus vaccine from Oxford and AstraZeneca shows positive response in early trial

By: Berkeley Lovelace Jr. and Lucy Handley
Source: CNBC
Date of Publication: July 20th, 2020
A potential coronavirus vaccine developed by Oxford University in the U.K. with pharmaceutical giant AstraZeneca has produced a promising immune response in a large, early-stage human trial.
Surging demand for medical equipment puts Philips on course for second-half recovery

Surging demand for medical equipment puts Philips on course for second-half recovery

By: Bart H. Meijer
Source: Reuters
Date of Publication: July 20th, 2020
Electrical equipment maker Philips said a recent surge in orders for scanners and other medical equipment should enable group sales and margins to rebound over the next six months from a slump in the second quarter.
N95 Face Mask Makers Ramp Up Production to Meet U.S. Covid-19 Demand - WSJ

N95 Face Mask Makers Ramp Up Production to Meet U.S. Covid-19 Demand

By: Austen Hufford
Source: The Wall Street Journal
Date of Publication: July 17th, 2020
American companies like 3M, Honeywell and Prestige Ameritech are investing in domestic production of masks.
CVS Covid-19 Test Results Are Taking Longer Than Customers Have Been Told - WSJ

CVS Covid-19 Test Results Are Taking Longer Than Customers Have Been Told

By: Scott Patterson, Sarah Krouse and Sharon Terlep
Source: The Wall Street Journal
Date of Publication: July 17th, 2020
Testees complain about waiting more than 10 days as coronavirus cases surge in U.S.
Demand For Abbott Labs Covid-19 Tests Surges Past 40 Million As Pandemic Cases Surge_Forbes

Demand For Abbott Labs Covid-19 Tests Surges Past 40 Million As Pandemic Cases Surge

By: Bruce Japsen
Source: Forbes
Date of Publication: July 16th, 2020
Abbott Laboratories said demand is surging for its portfolio of tests for the coronavirus strain Covid-19 as the pandemic triggers unprecedented need for its diagnostic products around the world.
Moderna spars with US scientists over COVID-19 vaccine trials

Exclusive: Moderna spars with U.S. scientists over COVID-19 vaccine trials

By: Marisa Taylor and Robin Respaut
Source: Reuters
Date of Publication: July 7th, 2020
As the United States accelerates the search for a coronavirus vaccine, tensions have erupted between government scientists and Moderna Inc, one of the leading developers, Reuters has learned.
U.S. government awards Novavax $1.6 billion for coronavirus vaccine

U.S. government awards Novavax $1.6 billion for coronavirus vaccine

By: Julie Steenhuysen
Source: Reuters
Date of Publication: July 7th, 2020
The U.S. government has awarded Novavax Inc $1.6 billion to cover testing, commercialization and manufacturing of a potential coronavirus vaccine in the United States, with the aim of delivering 100 million doses by January 2021.
COVID-19 — a timeline of the coronavirus outbreak

COVID-19 — a timeline of the coronavirus outbreak

By: Jenny Lei Ravelo, Sara Jerving
Source: Devex
Date of Publication: July 3rd, 2020
The timeline below tracks the development of the outbreak as it unfolds. Total cases as of July 3: 10,871,362 and 521,298 deaths.

Browse Collections

  • The Changing Nature of Work COVID-19

    The Changing Nature of Work

    From virtual offices to essential workers, explore how companies are adapting to changes in the way we work.
    Read More
  • Business on the Front Lines COVID-19

    Business on the Front Lines

    News and perspectives from corporations rising to the challenge of the COVID-19 public health crisis.
    Read More
  • Leading in a Crisis COVID-19.

    Leading in a Crisis

    Uncertainty can be disorienting and disruptive. Learn from business leaders about what it’s like to navigate their organizations and people through a global pandemic.
    Read More
  • Service and Community COVID-19

    Service and Community

    We’re in this together. Discover ways corporations are serving their communities and pivoting to become essential services.
    Read More